Skip to content

Clinical trials

Completed Myelodysplastic Syndromes trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Completed Country / region: Japan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20102
20111
20123
20132
20143
20151
20161
20173
20192
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene7
SymBio Pharmaceuticals5
Novartis Pharmaceuticals2
Astellas Pharma Global Development, Inc.1
Astex Pharmaceuticals, Inc.1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Janssen Pharmaceutical K.K.1
Keio University1
Millennium Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes24
Leukemia, Myeloid, Acute8
Leukemia, Myelomonocytic, Chronic5
Anemia3
Arrhythmias, Cardiac1
Constipation1
Diarrhea1
Heart Failure1
Hematologic Neoplasms1
Hemorrhage1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.